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Abstract
Parathyroid cancer is a rare disorder of unclear etiology that is difficult to diagnose and treat. It is most often diagnosed inci-
dentally based on multi-organ non-specific symptoms of hypercalcemia as a consequence of parathyroid hormone oversecre-
tion. We present a case of a male with primary hyperparathyroidism who was diagnosed with parathyroid cancer ectopically 
located in the mediastinum only after the third surgery. However, due to chronic hypercalcemia, problems with localization and 
a bad clinical condition, the patient was not able to undergo a radical resection and one year after the first pathological fracture 
died. Taking into consideration the whole clinical picture we want to emphasize the need to apply comprehensive differential 
diagnosis of hypercalcemia and localization diagnosis of parathyroid tissue with a use of MIBI scintigraphy accompanied by 
the computed tomography and magnetic resonance imaging, as the most specific diagnostic tools employed in this pathology. 
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Introduction
Parathyroid cancer is characterized by rather slow progres-
sion and low malignancy dynamic. It is estimated to comprise 
from 1% (in the US and Europe) to 5% (in Japan and Italy) of all 
cases of primary hyperparathyroidism (PHP) and only 0.005% of 
all tumors [1, 2]. In most cases the disease develops spontane-
ously though it may occur in patients with family history of the 
disorder. The diagnosis of parathyroid cancer is mainly based 
on the symptoms of resistant hypercalcemia caused by autono-
mous oversecretion of parathyroid hormone (PTH), which leads to 
disorders of the skeletal system, gastrointestinal tract, kidneys and 
often neck tumors [3, 4]. Localization tests include ultrasonogra-
phy, computed tomography (CT), magnetic resonance imaging 
(MRI) and parathyroid scintigraphy with 99mTc-hexakis2-metho-
xyisobutylisonitrile (99mTc-MIBI)  [5] and the method of choice 
is total resection followed by histological tests. 
The aim of this report is to present diagnostic difficulties in the 
localization of ectopic parathyroid cancer and draw attention to the 
need for accurate differential diagnosis of hypercalcemia. 
Case report
A 49-year-old male with no history of chronic illnesses was ad-
mitted to hospital in August 2011 due to the fracture of the shaft 
of the right humerus and fracture of the neck of the right femur 
after a fall from standing height. Fractures were surgically treated 
but the X-ray images showed cysts, which led to a more compre-
hensive diagnosis in search for abnormalities. Clinical picture and 
the conducted tests (Tables 1, 2) showed PHP with parathyroid 
adenoma and the patient was scheduled for parathyroidectomy. 
After the surgery the patient developed the so-called “hungry 
bone syndrome” (decrease in PTH and hypocalcemia). Laboratory 
tests also showed significant deficiency in vitamin D3 (3.7 ng/ml), 
decrease in urinary calcium (48 mg/24 hrs.) and a slightly higher 
level of chromogranin A (141 ug/l; n. 19–98). Due to the fact that the 
patient complained of pain, he underwent radiological examination 
which showed new fractures of the shaft of the left humerus and 
numerous fractures of the proximal and medial left femur. After 
achieving normal calcium level the patient was transferred to the 
Department of Orthopedics and Traumatology and scheduled for 
surgery. During the patient’s six-week-long hospital stay the levels of 
calcium (Ca), phosphor (P) and PTH were examined numerously. 
Both thyroid and adrenal gland disorders were excluded. The pa-
tient only manifested slightly higher parameters of inflammation. 
Due to progressive increase in PTH level observed from December 
2011, he was transferred to the Department of Endocrinology for 
further diagnosis and treatment. The patient manifested typical 
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symptoms of PHP: severe osteoporosis with numerous pathological 
fractures (Figure 1), diffuse decalcification of the spine and long 
bones, an episode of renal colic with kidney obstruction that had 
to be removed surgically and ulcerous disease. The patient under-
went conventional parathyroid 99mTc-MIBI subtraction scintigraphy 
which showed no accumulation of radiotracer (Figure 2). Only 
another examination with the use of SPECT imaging (subsequent 
single-photon emission computed tomography) revealed an area 
which could be enlarged parathyroid within the area of the central 
part of the right lobe of the thyroid which was confirmed by chest 
and neck CT (Table 2). Due to increasing levels of PTH and calcemia 
the patient was repeatedly and unsuccessfully operated on in the 
Department of Chest Surgery also with the use of a scintillation 
detector device (Table 2). Despite aggressive pharmacotheraphy 
(forced diuresis, steroids, bisphosphonates) the concentration 
of both PTH and Ca still grew with low levels of phosphor and 
magnesium. On 17 April 2012 we performed 18F-FDG-PET/CT 
(fluorodeoxyglucose-positron emission tomography) which re-
vealed a metabolically active lesion in the left area of the trachea 
below the piriform recess, which could be suggestive of enlarged 
parathyroid tissue (Figure 3). In the same month the patient under-
went another surgery (Table 2) complicated by circulatory arrest 
followed by successful resuscitation, however due to bad clinical 
condition the lesion was not removed.
The histological results conclusively confirmed the diagnosis of 
parathyroid cancer. By reason of persistent very high level of the 
PTH and hypercalcemia apart from a standard therapy the patient 
was also treated with Cinacalcet (Mimpara 3 x 60 mg/d), which 
Table 1. Laboratory test results
                                   Time 
Parameter
At baseline  
(August 2011)
After Surgery 1 
(October 2011)
December 2011 After Surgery 2 
(January 2012)
After Surgery 3 
(April 2012)
After Surgery 4 
(June 2012)
PTH concentration [pg/ml]
(n. 14–72)
> 1900 64 420–913 1113–1899 3930–5570 4730–4090
Total calcium [mg/dl]
(n. 8.4–10.4)
14.36 10.45–6.79 9.5–13 10.6–13.2 10.3-17.7 9.4–13.7
Phosphor [mg/dl]
(n. 2.4–5.1)
2.6 1.48–1.85 1.7–2.4 1.4–2.1 2.4-2.6 3.8–4.6
Table 2. Imaging and types of surgeries
Imaging Type of Surgery Histopathological results
At baseline
August 2011
Neck CT: “parathyroid adenoma within the lower pole of the left thyroid lobe”
Surgery 1
17 October 2011
Right parathyroidectomy “parathyroid adenoma, chief cells”
After Surgery 1 MIBI scintigraphy: “no scintigraphic lesions suggestive of enlarged parathyroid glands”
SPECT imaging “enlarged parathyroid gland within the area of the central part of the right lobe of the thyroid cannot be excluded”
Neck and Chest CT: “in the middle of the right thyroid lobe on the back wall on plain images visible tissue structure of 16 x 11 mm of a slightly 
lower optical density than the parenchyma of the gland, after administering contrast shows weaker enhancement and faster washout 
— could be consistent with enlarged parathyroid tissue”
Surgery 2
20 January 2012
Subtotal resection of the right and left lobe 
of the thyroid and isthmus with the use of 
a scintillation detector device
“...the morphological picture does not allow for accurate 
evaluation whether the parathyroid glands are normal or 
enlarged”
After Surgery 2 Neck and Chest CT: “below and towards the back from the trachea at Th4 visible focus of tissue, with round curves and diameter of 12 mm 
with visible deformation of the esophagus — parathyroid gland”
PET-CT (FDG): metabolically active lesion in the left area of the trachea below the piriform recess, which could be consistent with enlarged 
parathyroid
Whole body MIBI scintigraphy: “in the projection of the right lobe and in the midline of the body two areas of increased accumulation of MIBI”
Somatostatin receptor scintigraphy: “No lesions suggestive of overexpression of somatostatin receptors”
Surgery 3
25 April 2012
Total strumectomy with left parathyroidectomy Parathyroid cancer, immunohistochemistry: cyclin D1 (+), 
Galectin-3, Ki-64 (MiB1), positive in ca. 2% of the cells
After Surgery 3 Neck and Chest CT: “towards the back from the manubrium to the front from the brachiocephalic vein visible tissue areas contrast 
enhanced of total size ca. 12 x 32 x 31 mm. Towards the back from the trachea at Th4 visible polycyclic focus of tissue with round curves of 
size of ca. 19 x 25 x 30 mm contrast enhanced with visible deformation of the esophagus — significant progress as compared with the 
previous examination. Normal mediastinal and hilar lymph nodes”
Surgery 4
20 June 2012
Right thoracotomy — resection of mediastinal 
tumor
Morphological picture is consistent with parathyroid cancer, 
immunohistochemistry: cyclin D1 (+), Galectin-3, Ki-64 
(MiB1), positive in ca. 2% of the cells
After Surgery 4 Neck and Chest CT: “Behind the trachea on the right side (in the area of previously visible lesions) very small contrast enhanced area. 
Pathological tissues located behind the sternum, towards the front from the left brachiocephalic vein with no significant change as compared 
with the previous examination. Single mediastinal lymph nodes as previously”
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resulted in lower and more stable calcemia. In the interest of the 
patient who complained of shortness of breath and dysphagia 
and due to a rapidly progressing polycyclic mass lesion at Th4 
visible in CT imaging in June, he was operated on the fourth time. 
The mediastinal lesion built from the cells of parathyroid cancer 
was removed incompletely (Table 2). Moreover, the combination 
pharmacotheraphy was continued with the level of calcium within 
the upper normal range. The team of oncologists did not qualify 
the patient for chemo- and radiotherapy. In August 2012 the patient 
was transferred to a hospice where he soon died. 
Discussion
We report a clinical case of a male-patient whose pathological 
fractures underlying hypercalcemia were the primary manifesta-
Figure 1. Whole body bone 99mTc-MDP scintigraphy, AP and PA. 
Visible numerous areas of increased activity and metabolism of bone 
tissues are suggestive of fractures (arrows)
Figure 3. 18F-FDG PET/CT. PET-CT (A) and PET-MIP (B) Numerous 
areas of increased glucose metabolism in the skeletal system most 
probably connected with metastases and bone fractures (arrows)
Figure 2. Parathyroid scintigraphy with 99mTc-MIBI (A) with pertechnetate (B) using subtraction technique (C)
A B
C1 C2 C3
A B
C4
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tions of parathyroid cancer. Further tests showed a characteristic 
clinical picture of parathyroid cancer [2, 6] due to hypercalcemia: 
numerous cysts, diffuse decalcification of the spine, pathological 
fractures and lower density of the bone structure, calcinosis of the 
right renal medulla visible in ultrasonography, inflammation and 
defects in the membrane of the esophagus and stomach and 
duodenal ulcer visible in gastroscopy. Literature to date has shown 
that the diagnosis of parathyroid cancer is often incidental and 
radiographic findings of PHP account for 60–91% of all cases of 
parathyroid cancers [7]. Moreover, patients may suffer from overall 
weakness, fatigue, loss of appetite, loss of weight, depression, 
nausea, vomiting, constipation, polyuria and polydipsia, which 
were not observed in this patient. However, it should be borne in 
mind that there may be cases of non-secreting tumors with normal 
PTH and Ca levels which are more difficult to diagnose [8, 9]. In 
differentiation of parathyroid cancer and adenoma there are a few 
factors worth accounting for: the patient’s gender (the prevalence of 
the cancer is the same in men and women, however adenomas are 
three-fold more frequent in women than in men), the patient’s age 
(younger by 10–20 years than in the case of a benign lesion, i.e. 
at the age of 40 or 50), acute severe hypercalcemia (> 14 mg/dl), 
accompanying bone and renal lesions (in 40–60% of the patients) 
and quite often palpable neck mass [3, 10]. Such elements of 
differential diagnosis to a large extent can be found in our case. 
In case of suspicion of parathyroid cancer a key important stage 
is localization of the malignant lesion, especially in terms of its size 
and invasion, in order to allow for a radical, i.e. effective, surgery 
with a normal tissue margin. The problem of localizing parathyroid 
cancer is complicated by the fact that in 6–16% of the patients it can 
be found in non-typical places — most often in the thyroid (18%), 
the thymus (38%) or behind the esophagus (31%) [11]. One of the 
simplest, safest and repeatable imaging is ultrasonography, how-
ever, its sensitivity (50–60%) is insufficient and it can mainly be used 
in localizing lesions in the neck and thyroid. A test of choice in the 
localization diagnosis of enlarged parathyroid glands is 99mTc-MIBI 
scintigraphy which is also effective in localizing ectopic lesions and 
distant metastases [12, 13]. But the effectiveness of this method 
directly depends on the size of the lesion. So, according to Roy et 
al. the sensitivity of conventional method is 89%, and increase even 
up to 95% when use MIBI scintigraphy and ultrasonography [12]. 
Even better results can be obtained by use of hybrid imaging 
combining MIBI scintigraphy and CT or MRI with contrast and fat 
suppression which allows for the assessment of the details of the 
pathological tissues, its relations with other structures and their 
invasion of neighboring tissues or enlarged lymph nodes [14]. Due 
to better resolution and more precise localization of the lesion in 
three dimensions as compared to the classic scintigraphy, the use 
of SPECT imaging in recent years has increased. To detect remote 
metastases we use FDG-PET which can give false positive results. 
In complex cases a patient may undergo catheterization of cervical 
veins to determine the concentration of PTH [15]. It should be em-
phasized that in our case no significant pathologies were found in 
ultrasonography, while a suspicious focus that could be diagnosed 
as parathyroid lesion was visible only in the CT.
However, only after the second surgery in the chest CT we found 
the focus of PTH secretion in the mediastinum, which unfortunately 
could not be completely removed. Unfortunately, this patient did 
not undergo MIBI scintigraphy before the surgery. The examination 
performed postoperatively proved to be unreliable due to anatomi-
cal and surgical tissue damage. Yet again we would like to underline 
how crucial it is to employ this type of scintigraphy before applying 
the right course of action.
Owing to the histological difficulties in diagnosing parathyroid 
cancer visible in our case where the diagnosis was possible only 
after the third surgery, there was a need to employ other diagnos-
tic methods based on immunohistochemistry and DNA analysis. 
These new markers include parafibromin, expression of Rb, Ki-67 
and Galectin-3. Unfortunately, none of these has enough sensitivity 
and specificity on its own, therefore their results need to be interpret 
the results jointly [3, 16]. 
The only efficient method of treating parathyroid cancer is a total 
resection of the primary tumor, which is very demanding owing to the 
problems with localizing parathyroid tissue. The efficacy of surgery 
can be evaluated intraoperatively on the basis of the decrease of 
PTH concentration per minute [17]. It is 50% in comparison with 
the highest input level. Taken the above into consideration the first 
surgery performed on the patient should be deemed efficient as we 
obtained normalization of the parathyroid hormone concentration 
and the patient even developed hypocalcemia. Unfortunately, quite 
quickly the parathyroid tissue grew back from the cells which had 
remained in the mediastinum. This fact proved how crucial it is to 
localize and assess the invasion of pathological parathyroid tissue 
and perform complete resection with a margin of healthy tissue. It 
should be underlined here that all farther images of the neck were 
more difficult to evaluate because of fibrous tissue which formed 
after the surgeries. Therefore, it is critically important to localize 
the pathological lesion at the beginning of the disease. In our case 
upon the right diagnosis and localization of the tumor the patient 
did not qualify for a total resection of the lesion due to numer-
ous complications and great extent of the malignant infiltration. After 
the non-radical resection of the tumor due to its low accessibility 
the progression of the lesion occurred quickly compressing the 
respiratory track and the patient needed another surgery. 
Conclusions
Parathyroid cancer is a rare and slowly progressing pathology 
with quite good prognosis when diagnosed quickly and accu-
rately. However, there are no clear diagnostic criteria or no clear 
courses of treatment. The only confirmed course of treatment that 
translates into prognosis and morbidity is a total resection with 
a margin of healthy tissue. The efficacy of the surgery is strictly 
connected with best localization of the pathological parathyroid 
tissue. That is why it is crucial to differentiate hypercalcemia and 
diagnose the patient before embarking on any therapy. In the 
localization diagnosis a method of choice is parathyroid MIBI 
scintigraphy accompanied by the computed tomography and 
magnetic resonance imaging, as together they provide almost 
100% detectability. It is important that in every case of incidentally 
diagnosed hypercalcemia we exclude parathyroid cancer as one of 
the causes. The differentiation of the malignant process from para-
thyroid adenoma before the surgery affects the extensiveness of 
the surgical procedure, which in turn affects the patient’s morbidity. 
The diagnostic difficulties encountered in our case emphasize the 
fact the right diagnosis should be based on the clinical picture, 
laboratory and radiological test results.
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